We found 3 mohs skin cancer surgeons who accept Blue Cross and Blue Shield of Florida BlueOptions All Copay near Miami, FL.

Showing 1-3 of 3
Dr. Manuel A Iriondo, MD
Specializes in MOHS-Micrographic Surgery
3661 S Miami Avenue; Suite 506
Miami, FL

Dr. Manuel Iriondo sees patients in Miami, FL and Coral Gables, FL. His medical specialty is MOHS-micrographic surgery. In addition to English, he speaks Spanish. Clinical interests for Dr. Iriondo include skin issues. He is affiliated with Baptist Hospital. After completing medical school at Texas Tech University Health Sciences Center, Paul L. Foster School of Medicine and Higher Institute of Medical Sciences of Havana, he performed his residency at Texas Tech University Health Sciences Center. Blue Cross/Blue Shield, Coventry, and Blue Cross Blue Shield EPO are among the insurance carriers that Dr. Iriondo honors.

Read more

Clinical interests: Skin Issues

No Photo
Specializes in MOHS-Micrographic Surgery
1475 Nw 12 Avenue; Box 016960
Miami, FL

Dr. Keyvan Nouri is a mohs skin cancer surgeon. Blue Cross/Blue Shield, Blue Cross Blue Shield EPO, and Blue Cross Blue Shield Bronze are among the insurance carriers that Dr. Nouri accepts. He graduated from Boston University School of Medicine. Dr. Nouri trained at a hospital affiliated with the University of Miami for residency. Awards and/or distinctions he has received include Struthmore's Who's Who VIP Member; Young Investigators Award @ Advance Wound; and Physician of the Quarter at Sylvester Comrehensive Cancer Center in Miami. Dr. Nouri is conversant in Persian. He has a closed panel.

Read more
Dr. Francisco Flores, MD
Specializes in MOHS-Micrographic Surgery
590 E. 25th Street; Suite 302
Hialeah, FL

Dr. Francisco Flores' specialty is MOHS-micrographic surgery. Dr. Flores is conversant in Spanish. He is professionally affiliated with Memorial Hospital Miramar. He graduated from the University of Miami, Miller School of Medicine. Dr. Flores trained at Jackson Memorial Medical Center for his residency. Patient ratings for Dr. Flores average 3.0 stars out of 5. He takes Blue Cross Blue Shield EPO, Blue Cross Blue Shield Bronze, Blue Cross Blue Shield HMO, and more.

Read more

Conditions / Treatments


New Patients

Medicare Patient Age

Medicare Patient Conditions

Medicare Patient Ethnicity

Additional Information


Foreign Language

Online Communication

Practice Affiliation

Time Commitments


Medical School


What is MOHS-Micrographic Surgery?

Mohs micrographic surgery is a surgical treatment for skin cancer that was developed by Dr. Frederick Mohs in the 1930’s. It is the most effective technique for removing the most common types of skin cancer. For the two most common types of skin cancer, basal cell carcinoma and squamous cell carcinoma, Mohs has a 98-99% cure rate. The remarkable thing about Mohs is that it manages to be extremely good at removing all of the cancer cells while at the same time leaving behind most of the healthy tissue, so there is a smaller wound. This makes the procedure safer, speeds up the the recovery time, and minimizes scarring.

During Mohs surgery, skin around the cancer site is mapped out and removed in thin layers. Then each layer is examined under a microscope for cancer cells, while the surgery is in progress. If cancer cells are detected, the surgery continues and another layer is removed. If the skin is clear, the surgery can be stopped. This eliminates the guesswork for surgeons. There is no need to estimate the borders or roots of the cancer and no need to remove a margin of healthy tissue to ensure that all of the cancer is removed.

Even though Mohs has a high cure rate, is safer than other treatments, and takes less tissue, not every skin cancer is treated with Mohs. First, Mohs takes quite a bit longer than traditional surgery because each layer of skin must be carefully cut, prepped, and examined. It is also more expensive and may not always be covered by insurance. In addition, for smaller or less aggressive cancers that are easier to treat, the cure rate for non-Mohs treatments is close to that of Mohs; thus, the extra time and cost of Mohs might not be justified. Other kinds of skin cancer, such as melanoma, are hard to see under a microscope. Since melanoma is so dangerous, Mohs has traditionally not been used to treat it, as there is too much risk for missed cancer cells being left behind in the body. However, recent developments in stains (which make cancer cells more visible under a microscope) may change the role of Mohs in melanoma treatment.

Mohs microsurgery has changed the way doctors treat skin cancer in the past 80 years, and it continues to gain in popularity as it increases the effectiveness and safety of skin cancer treatment.